tazobactam has been researched along with ppi-0903 in 4 studies
Studies (tazobactam) | Trials (tazobactam) | Recent Studies (post-2010) (tazobactam) | Studies (ppi-0903) | Trials (ppi-0903) | Recent Studies (post-2010) (ppi-0903) |
---|---|---|---|---|---|
1,327 | 153 | 694 | 519 | 39 | 451 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 3 (75.00) | 2.80 |
Authors | Studies |
---|---|
Rademacher, J; Welte, T | 1 |
Anguita-Santos, F; Aznarte-Padial, MP; Borreguero, I; Castón, JJ; Corzo-Delgado, JE; Esteban-Moreno, MÁ; Herrero-Rodríguez, C; Jiménez-Aguilar, P; López-Cárdenas, S; Maldonado, N; Martín-Aspas, A; Martínez-Marcos, FJ; Ojeda-Burgos, G; Palacios-Baena, ZR; Praena-Segovia, J; Retamar, P; Rodríguez-Baño, J; Rosso-Fernández, CM; Valiente de Santis, L | 1 |
Bassetti, M; Giacobbe, DR; Pelosi, P; Robba, C; Vena, A | 1 |
Cheng, B; Guo, P; Jia, P; Xu, Y; Yang, Q; Zhang, H; Zhu, Y | 1 |
2 review(s) available for tazobactam and ppi-0903
Article | Year |
---|---|
[New antibiotics - standstill or progress].
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Infections; Ceftaroline; Ceftazidime; Cephalosporins; Clinical Trials as Topic; Drug Approval; Drug Combinations; Drug Resistance, Multiple, Bacterial; Ephedrine; Humans; Macrolides; Methicillin-Resistant Staphylococcus aureus; Organophosphates; Oxazoles; Penicillanic Acid; Phenobarbital; Staphylococcal Infections; Tazobactam; Theophylline; Triazoles | 2017 |
Treatment of extended-spectrum β-lactamases infections: what is the current role of new β-lactams/β-lactamase inhibitors?
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Ceftaroline; Ceftazidime; Cephalosporins; Cyclooctanes; Drug Combinations; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Piperacillin, Tazobactam Drug Combination; Public Health; Sepsis; Tazobactam | 2020 |
2 other study(ies) available for tazobactam and ppi-0903
Article | Year |
---|---|
Quasiexperimental intervention study protocol to optimise the use of new antibiotics in Spain: the NEW_SAFE project.
Topics: Antimicrobial Stewardship; Azabicyclo Compounds; Ceftaroline; Ceftazidime; Cephalosporins; Clinical Protocols; Drug Combinations; Humans; Interrupted Time Series Analysis; Medication Systems; Oxazolidinones; Practice Patterns, Physicians'; Spain; Tazobactam; Teicoplanin; Tetrazoles | 2020 |
In vitro activity of ceftaroline, ceftazidime-avibactam, and comparators against Gram-positive and -negative organisms in China: the 2018 results from the ATLAS program.
Topics: Ampicillin; Anti-Bacterial Agents; Azabicyclo Compounds; Ceftaroline; Ceftazidime; Cephalosporins; Colistin; Drug Combinations; Escherichia coli; Gram-Negative Bacteria; Gram-Positive Bacteria; Imipenem; Klebsiella pneumoniae; Levofloxacin; Meropenem; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Piperacillin; Tazobactam; Tigecycline | 2022 |